These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 20683038)

  • 21. Immunohistochemical reevaluation of carbonic anhydrase IX (CA IX) expression in tumors and normal tissues.
    Luong-Player A; Liu H; Wang HL; Lin F
    Am J Clin Pathol; 2014 Feb; 141(2):219-25. PubMed ID: 24436269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteopontin but not parathyroid hormone-related protein predicts prognosis in human renal cell carcinoma.
    Papworth K; Bergh A; Grankvist K; Ljungberg B; Sandlund J; Rasmuson T
    Acta Oncol; 2013 Jan; 52(1):159-65. PubMed ID: 22731830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and diagnostic implications of carbonic anhydrase IX in several tumours with predominantly clear cell morphology.
    Lin XY; Zhang H; Tang N; Zhang XP; Zhang W; Wang EH; Han YC
    Histopathology; 2015 Apr; 66(5):685-94. PubMed ID: 25431204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.
    Driessen A; Landuyt W; Pastorekova S; Moons J; Goethals L; Haustermans K; Nafteux P; Penninckx F; Geboes K; Lerut T; Ectors N
    Ann Surg; 2006 Mar; 243(3):334-40. PubMed ID: 16495697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RENCA/carbonic anhydrase-IX: a murine model of a carbonic anhydrase-IX-expressing renal cell carcinoma.
    Shvarts O; Janzen N; Lam JS; Leppert JT; Caliliw R; Figlin RA; Belldegrun AS; Zeng G
    Urology; 2006 Nov; 68(5):1132-8. PubMed ID: 17095063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors.
    Cetin B; Gonul II; Buyukberber S; Afsar B; Gumusay O; Algın E; Turan N; Ozet A; Benekli M; Coskun U
    Tumour Biol; 2015 Nov; 36(11):8471-8. PubMed ID: 26026587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and ¹²⁴I-cG250 PET/CT.
    Lawrentschuk N; Lee FT; Jones G; Rigopoulos A; Mountain A; O'Keefe G; Papenfuss AT; Bolton DM; Davis ID; Scott AM
    Urol Oncol; 2011; 29(4):411-20. PubMed ID: 19523858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
    Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
    Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
    Swinson DE; Jones JL; Richardson D; Wykoff C; Turley H; Pastorek J; Taub N; Harris AL; O'Byrne KJ
    J Clin Oncol; 2003 Feb; 21(3):473-82. PubMed ID: 12560438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Kamei S; Deguchi T; Hirose Y
    Oncol Rep; 2008 Sep; 20(3):525-30. PubMed ID: 18695901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature.
    Zhao Z; Liao G; Li Y; Zhou S; Zou H; Fernando S
    PLoS One; 2014; 9(11):e114096. PubMed ID: 25426861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbonic anhydrase expression in kidney and renal cancer: implications for diagnosis and treatment.
    Oosterwijk E
    Subcell Biochem; 2014; 75():181-98. PubMed ID: 24146380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma.
    Leppert JT; Lam JS; Pantuck AJ; Figlin RA; Belldegrun AS
    BJU Int; 2005 Aug; 96(3):281-5. PubMed ID: 16042714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunohistochemical expression of microvascular density and carbonic anhidrase IX in renal carcinoma. Relation to histological type and tumoral progression].
    Rubio-Briones J; Calatrava A; Fernández-Serra A; Ramos Ruiz R; Iborra I; García-Casado Z; Rubio L; Trassierra M; Collado A; Casanova J; Gómez-Ferrer A; Solsona E; López-Guerrero JA
    Actas Urol Esp; 2011 Feb; 35(2):80-6. PubMed ID: 21256634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up.
    Zhang BY; Thompson RH; Lohse CM; Dronca RS; Cheville JC; Kwon ED; Leibovich BC
    BJU Int; 2013 Jun; 111(7):1046-53. PubMed ID: 23551810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
    Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E
    Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbonic anhydrase IX as a predictive biomarker for clear cell renal cell carcinoma.
    Pantuck AJ; Klatte T; Seligson D; Atkins M; Belldegrun A
    J Clin Oncol; 2008 Jun; 26(18):3105-7; author reply 3107-9. PubMed ID: 18565906
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
    Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
    Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.